 |
|
Wait-and-See Prescription for Acute Otitis Media—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: Dr Johnson makes a good point, and it would be interesting for Dr Spiro and colleagues to confirm whether prior duration of prolonged and severe symptoms was in effect an exclusion criterion for their study. If such children were included, the study is perhaps unlikely to have the power to assess adverse outcomes in such groups because few children are likely to have severe prior symptoms for more than 3 days. When presenting the study protocol to physicians interested in participating in a study of delayed prescribing,1 my colleagues and I made it clear that the approach to delaying had to be pragmatic and modified by prior duration of severe illness. In a large Dutch cohort, the only child to develop mastoiditis waited significantly longer than 3 days before getting antibiotics.2 Thus, given the nature of the existing evidence, it would perhaps be unwise to allow children with . . . [Full Text of this Article]
Paul Little, MBBS, MD, FRCGP
P.Little@soton.ac.uk
Community Clinical Sciences Division
University of Southampton
Aldermoor Health Centre
Southampton, United Kingdom
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED LETTERS
Wait-and-See Prescription for Acute Otitis Media
James R. Johnson
JAMA. 2007;297(2):152.
EXTRACT
| FULL TEXT
Wait-and-See Prescription for Acute Otitis Media—Reply
David M. Spiro and Eugene D. Shapiro
JAMA. 2007;297(2):152-153.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Wait-and-See Prescription for the Treatment of Acute Otitis Media: A Randomized Controlled Trial
David M. Spiro, Khoon-Yen Tay, Donald H. Arnold, James D. Dziura, Mark D. Baker, and Eugene D. Shapiro
JAMA. 2006;296(10):1235-1241.
ABSTRACT
| FULL TEXT
|
